Governor Andrew M. Cuomo announced three design-build teams have been selected to receive a Request for Proposals, enabling them to compete for a contract for the design and construction of a new $750 million world-class, state-of-the-art public health laboratory that will replace Wadsworth Center’s aging facilities. The lab is expected to attract approximately 1,200 life sciences jobs and generate about $2.3 billion in economic activity for the region over the life of the project.
“New York’s commitment to the life sciences sector has never been stronger, and with this project, we will build one of the world’s most sophisticated public health research laboratories that will further advance our position as a leader in this emerging industry,” Governor Cuomo said. “Innovative research and development will advance scientific breakthroughs out of the lab and into the real world, saving lives, creating jobs and driving billions of dollars in economic development across the state.”
Envisioned as “A Lab for the 21st Century,” the new facility, to be located on Albany’s W. Averell Harriman State Office Building Campus, will function as a magnet for future private-sector investments and public-private collaboration, accelerating innovation and value creation. The modern facility and committed co-investments will serve as a flagship project for New York State, signaling a strong and long-term commitment to the Capital Region’s growing life sciences industry.
The Dormitory Authority of the State of New York will oversee the design and construction of the state-of-the-art facility, working closely with the New York State Department of Health and Empire State Development. DASNY is authorized to use design-build for the project. This alternative project delivery method combines design and construction services in a single contract to expedite project delivery and provide savings while maintaining a high level of quality.
Dr. Gerrard P. Bushell, President & CEO of DASNY said, “…Building a complex, 21st-century infrastructure requires sophisticated delivery methods. Design-build will help us complete this vitally important facility on time, on budget, and as swiftly as possible.”
DASNY previously issued a Request for Qualifications seeking qualified design-build entities to design and construct the new life sciences laboratory. Following a thorough review, a shortlist of design-build entities have been selected to continue with the development process and respond to the RFP. The teams selected to receive the RFP and compete for the design-build contract are:
- AECOM Tishman/Skanska USA
- Gilbane Building Company/Turner Construction
- Pike McCarthy Joint Venture
To foster participation in the project by minority-owned, women-owned, small, and service-disabled veteran-owned businesses, DASNY will be hosting an Industry Day with the three selected teams. This event will provide a forum for various firms from all disciplines and specialties to learn more about the project, identify opportunities, and network with these RFP recipients for possible subcontracting opportunities on the project. The event will take place:
Tuesday, March 26
1:00 – 5:00 p.m.
Albany Capital Center
New York State’s $620 Million Life Science Initiative
The lab is being developed in coordination with New York State’s $620 million initiative, enacted in the FY 2018 budget, to spur the growth of a world-class life sciences research cluster in New York, as well as expand the state’s ability to commercialize this research and grow the economy.
This multi-faceted initiative includes $100 million to expand the Excelsior Jobs Program Tax Credit across the life sciences industry, $100 million for a life sciences research and development refundable tax credit program and $320 million in other forms of investment. This includes State capital grants to support the development of wet-lab and innovation space, operating support and investment capital for early-stage life sciences companies that leverage an additional match of at least $100 million from the private sector.
The Life Sciences sector encompasses the fields of biotechnology, pharmaceuticals, biomedical technologies, life systems technologies, and includes organizations and institutions that devote the majority of their efforts to the various stages of research, development, technology transfer and commercialization. Every day, firms in this sector are developing new medical and pharmaceutical breakthroughs that have the potential to save lives, whether through new therapies or the early detection of diseases like autism and cancer. These firms are also making significant advancements in the realms of agriculture and environmental biotechnologies, helping create a cleaner and more sustainable future.
By strengthening incentives, investing in the facilities, and improving access to talent and expertise, New York will significantly increase its share of industry-funded research and development, support the commercialization of existing academic research, and usher in the next generation of advanced technologies. Beyond the advancements in science, this initiative will position New York as a magnet for emerging manufacturing-based enterprises, bolstering regional economies and creating thousands of jobs.